Investors
List of the current and past investors into Delenex Therapeutics AG with their respective financial instruments.| Investor | Profile | Country | Phone | Round | |||
|---|---|---|---|---|---|---|---|
|
Clarus Ventures LLC | Life sciences venture capital firm | United States | +1 (617) 949-2200 | N/A | ||
|
Hatteras Venture Partners II (HVP II) | United States | +1 (919) 484-0730 | N/A | |||
|
HBM BioVentures AG | Switzerland | +41 (41) 768-1108 | Series A | |||
|
Novo A/S | Denmark | Series A | ||||
|
SV Life Sciences Advisers Inc | United States | +1 (617) 367-8100 | Series A | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
VI Partners AG | Switzerland | +41 (41) 729-0000 | Series A |